- Home
- BTOG vs BMRA Comparison
BTOG vs BMRA Comparison
Compare BTOG & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BTOG | BMRA |
|---|---|---|
| Founded | 2018 | 1971 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6M | 6.3M |
| IPO Year | 2018 | 1995 |
Fundamental Metrics
Financial Performance| Metric | BTOG | BMRA |
|---|---|---|
| Price | $2.28 | $2.17 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 38.3K | 24.3K |
| Earning Date | 03-31-2026 | 04-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $5,311,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.08 | $0.40 |
| 52 Week High | $5.96 | $4.60 |
Technical Indicators
Market Signals| Indicator | BTOG | BMRA |
|---|---|---|
| Relative Strength Index (RSI) | 45.12 | 52.69 |
| Support Level | $2.20 | $2.11 |
| Resistance Level | $2.69 | $2.23 |
| Average True Range (ATR) | 0.20 | 0.11 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 28.13 | 77.78 |
Price Performance
Historical ComparisonAbout BTOG Bit Origin Limited
Bit Origin Ltd is seeking opportunities in deploying new technologies, crypto asset mining and blockchain technologies in Singapore. The company has focused on building the Bitcoin mining ecosystem through incubations, strategic investments, and acquisitions. It derives all of its revenue from Bitcoin mining.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.